Sur cette page

Q&As (General): NPs prescribing controlled substances

On April 19, 2017, government approved regulations to expand NPs’ scope of practice to include prescribing controlled substances.

What are controlled substances and why are they restricted?

A controlled substance is one that is included in Schedule I, II, III, IV or V of the federal Controlled Drugs and Substances Act. Controlled substances are used in healthcare to treat a wide variety of conditions including, but not limited to, pain, anxiety, epilepsy and sleep disorders. They include opioids, benzodiazepines, amphetamines, sedatives, anti-emetics and hormonal therapies, among others. Controlled substances are restricted because they present a high risk for potential misuse, addiction and diversion.

Can NPs prescribe controlled substances?

Only NPs who have successfully completed College approved controlled substances education are authorized to prescribe controlled substances in Ontario. For more information about the education, read Q&As: Controlled Substances Education Requirement.

Are there any controlled substances that NPs can’t prescribe?

Yes, regulations under the federal law prohibit NPs from prescribing the following controlled substances:

  • diacetylmorphine (heroin)
  • opium (such as opium and belladonna suppository)
  • coca leaves (such as cocaine) and
  • anabolic steroids except testosterone (NPs are authorized to prescribe testosterone.)

Also, NPs in Ontario can only prescribe methadone with a Health Canada exemption (see next question for details).

Can NPs prescribe methadone?

Methadone is regulated more rigorously than other controlled substances. A Health Canada exemption is required to prescribe it. At this time, there is no process for individual NPs to obtain this Health Canada exemption.

However, there is one exception. If specific terms and conditions are met, there’s an exemption that allows prescribers (such as physicians and NPs) working in hospitals to prescribe methadone to clients who are admitted to hospital and who have a prior methadone prescription. If an NP is prohibited from prescribing controlled substances, they cannot prescribe methadone under this exemption.

Details of the mandatory terms and conditions are on Health Canada's website.

Not meeting these terms and conditions may result in a contravention of the Controlled Drugs and Substances Act and its regulations.

In addition to the terms and conditions, NPs are expected to meet the accountabilities outlined in the Nurse Practitioner practice standard and ensure they have the competence to prescribe methadone.

Additional resources:

How can I tell if an NP is authorized to prescribe controlled substances?

You can use the College’s register Find a Nurse to check whether an NP is authorized to prescribe controlled substances. NPs who are not authorized to prescribe controlled substances are identified on the register as “Entitled to Practise with Restrictions” with a description that states: "This member cannot prescribe controlled substances. They have not completed the education needed to do so."

What evidence supported the changes to NP scope of practice?

A significant amount of policy work was done to inform decision-making, including:

  • an analysis of relevant legislation
  • literature reviews
  • a review of other regulators’ policies

A national working group under the Canadian Council of Registered Nurse Regulators established a national approach to regulating this new area of practice. Joint work included a literature review, identifying education competencies and courses, as well as next steps to be taken within each jurisdiction (for example, integrating into program approval).

In 2013, the College conducted a survey of Ontario NPs to better understand practice realities associated with the use of controlled substances (for example, relevance of specific controlled substances to their practice setting/client population, learning needs, existing supports, and attitudes and concerns about the risks associated with controlled substances). In addition, in 2014 and 2016, the College consulted on proposed core competency indicators and practice expectations with several key stakeholders.

Isn’t prescribing controlled substances a risky activity? Why give NPs this authority now?

Yes. Activities associated with controlled substances are high risk (e.g., potential for misuse, addiction, diversion). Yet these risks need to be balanced with ensuring clients have access to appropriate treatment. Ontario NPs frequently assess clients with conditions that may require controlled substances for treatment. If NPs can’t prescribe controlled substances, clients may not get the treatment they need or their treatment may be delayed.

Safe, effective and ethical prescribing includes practitioners being able to assess and identify potential and actual medication misuse, addiction and diversion. Education and other regulatory mechanism will address the risks associated with controlled substances so NPs can prescribe safely, effectively and ethically.

Can I phone in a prescription for a controlled substances to a pharmacy?

Telephone orders and other verbal orders should only be used in limited circumstances as there are inherent risks with using verbal orders. Under federal law, certain controlled substances (most narcotic medications) cannot be ordered without a written prescription. If phoning prescriptions to a pharmacy, NPs should ensure that the medication can be prescribed by phone and should document the rationale for why they needed to do so by telephone.

The Ontario College of Pharmacists provides a resource that may be helpful: Prescription Regulation Summary Chart (Summary of Laws) or visit their website – http://www.ocpinfo.com/.

Am I allowed to order controlled substances with refills?

Under federal law, there are specific requirements about refills for controlled substances.

  • Refills are not permitted for narcotics
  • Refills are permitted for benzodiazepines and targeted substances by either a written or telephone prescription that specifies the number of refills
  • Prescriptions (including any refills authorized) for benzodiazepines and targeted substances expire within a year
  • Refills for part I controlled drugs (e.g., amphetamines) are permitted by a written prescription only, and must specify the number of refills and refill dates (or intervals between refills)
  • Refills for part II controlled drugs (e.g., barbiturates) and part III controlled drugs (e.g., testosterone) are permitted by either a written or telephone prescription, and must specify the number of refills and refill dates (or intervals between refills)

The Ontario College of Pharmacists provides a resource that may be helpful: Prescription Regulation Summary Chart (Summary of Laws).

You must meet the expectations for prescribing controlled substances outlined in the Nurse Practitioner practice standard. These include prescribing a quantity of controlled substances to be dispensed that balances the need to reassess and monitor the client with the risk of harm that may result if the client runs out of medication. NPs providing episodic care should prescribe the minimum amount necessary until the client can be assessed by their regular care provider.

I’m involved in procuring medications for my practice setting. Are there any legal requirements around reporting theft of controlled substances?

There are legal requirements under the Controlled Drugs and Substances Act related to record-keeping and reporting theft of these medications. You must report the loss or theft of controlled substances to Health Canada’s Office of Controlled Substances within 10 days.

I’ve heard that federal law allows NPs to prescribe marijuana. Can I sign a medical document stating that my client is eligible for medical marijuana?

Yes. NPs are authorized to sign a medical document stating that their client is eligible for medical marijuana. You are accountable for ensuring that medical marijuana is an appropriate evidence-based treatment for your client. You are also accountable for meeting the accountabilities around therapeutic management outlined in the Nurse Practitioner practice standard.

NPs completing a medical document authorizing a client to access medical marijuana should counsel the client about risks, side effects, safe storage and the importance of obtaining the marijuana from a legal source. NPs must comply with requirements under the Access to Cannabis for Medical Purposes Regulations. As outlined in the regulations, NPs may only provide medical documents for clients under their professional treatment. NPs must provide specific information on the medical document, including:

  • the NP’s full name, professional designation, registration number, contact information (business address, phone, fax and email, if applicable), address of the location at which the client consulted with them
  • the client’s full name and date of birth
  • daily dose of marijuana in grams that a client can take, and
  • the period of use (maximum 1 year), which begins on the day on which the medical document is signed by the practitioner.

The NP must sign and date the medical document.

Additional resources:

I’m an NP that is not authorized to prescribe controlled substances. What do I do if I determine a client requires a prescription for a controlled substance?

NPs can expect to encounter clients requiring prescriptions for controlled substances, since many medications are controlled substances.  You should plan for this anticipated client care need by establishing strategies consistent with College standards and guidelines. You should also work with your employer to ensure you have access to resources for meeting client needs. In this case, the resource you need is the ability to refer to a health professional such as an NP or physician authorized to prescribe controlled substances. The client’s prescription must be filled out by the authorized prescriber in a manner that is consistent with their regulatory obligations.   

NPs who are not authorized to prescribe controlled substances must not taper a controlled substance or renew a prescription for a controlled substance as these are considered prescribing.

If you commonly encounter clients in your practice that require controlled substances you should consider completing the education requirement that would authorize you to prescribe controlled substances. As expected for any activity, you may have additional learning needs you have to meet, relevant to your setting and client population.

I’m an NP who is not authorized to prescribe controlled substances. I assessed a client and determined that she needs treatment with a controlled substance. The physician I work with agreed with my findings and proposed a treatment plan. Can I complete this prescription based on the outcome of my consultation with the physician?

No. Consulting with a physician does not give you the legal authority to prescribe any medication. The authority to prescribe medication comes from the legislation. Therefore, in this case the physician should be asked to prescribe the controlled substance. Physicians have their own professional accountabilities, which may also require them to personally assess the client.

Where can I find information about Ontario’s Narcotics Strategy, and the Narcotics Monitoring System?

Information about Ontario's Narcotics Strategy and the Narcotics Safety and Awareness Act, 2010 can be found on the Ministry of Health's website. As part of the Narcotics Strategy, the province has established the Narcotics Monitoring System (NMS) to monitor the prescribing and dispensing of controlled substances. Although its name implies the monitoring of narcotics, the NMS monitors all controlled substances as well as opioids that are not controlled substances (such as medications containing Tramadol). The main purpose of the NMS is to examine drug-use patterns to inform harm reduction strategies and education initiatives, and improve prescribing and dispensing practices related to monitored drugs. If illegal activity or professional misconduct is suspected, the Ministry may report information from the NMS to law enforcement bodies and regulatory colleges. 

Can I dispense medications that are controlled drugs and substances?

Yes, you can dispense a controlled substance that you prescribed or that was ordered by a physician or dentist with whom you work. The Nurse Practitioner and the Medication practice standards describe the practice expectations for public protection when dispensing medication.

Rather than standalone controlled substances courses, shouldn’t the course content be integrated into NP curriculum?

Yes. Now that prescribing controlled substances is part of NPs’ scope of practice, it will eventually be integrated into NP program curriculum. This will likely be in place sometime in 2018. Members and applicants who didn’t have this content in their NP program can take Council-approved controlled substances courses to gain foundational competencies that are unique to controlled substances, and meet the education requirement set out in regulation.

How will this new authority affect medical assistance in dying?

Medical assistance in dying protocols may require controlled substances. This regulation change may enable NPs to provide medical assistance in dying protocols (in accordance with legal requirements). See Guidance on Nurses’ Role in Medical Assistance in Dying for a description of legal and professional requirements.

How often am I required to complete approved controlled substances education?

This is a one-time requirement to gain foundational competencies that are unique to controlled substances. You may have other learning needs related to controlled substances. As part of commitment to continuing competence and quality improvement, you are expected to engage in practice reflection to identify learning needs, and set and achieve learning goals.

Can I dispense medications that are controlled drugs and substances?

Yes, you can dispense a controlled substance if it has been ordered by a physician or dentist with whom you work. The practice expectations for public protection when dispensing medication are described in the Nurse Practitioner practice standard.I notice that I may be required to put an “identification number” on a medication that I dispense. What is the identification number?

The identification number is assigned to track medications from the point of procurement to the point they are provided to a client. The purpose of an identification number is to trace a medication back to the manufacturer. In the event of safety concerns (e.g., a medication recall), the identification number enables health professionals to follow up with clients appropriately.

You should consult your employer about whether this tracking system exists in your practice setting and how to obtain the identification number. If such a system does not exist, you should advocate for measures to ensure safe medication practices. If you are self-employed, you are expected to establish your own tracking system. The practice expectations for public protection when dispensing medication are described in the Nurse Practitioner practice standard.

Why is the drug manufacturer’s name required on the label of a medication I dispense? What if this information is not available to me?

Including the manufacturer’s name is another mechanism used for tracking medication. Depending on your practice setting, this information may not be readily available to you. For example, if you are dispensing medication from a supply that is stocked by a pharmacist, the medication may have been re-packaged, and therefore, while this information is available to the pharmacist, it is not available to you. If you do not have access to this information, then you are not required to include it.

When an NP is compounding a cream for topical application, the NP is expected to have the manufacturer’s original packaging for the various substances used in the compound. Therefore, when compounding, you must include the manufacturer’s name on the label if the compound is being dispensed to a client.

Is it a conflict of interest for NPs who prescribe a medication to also dispense or sell that medication?

No. The College has developed specific conflict-of-interest provisions to reduce the risk of NPs finding themselves in a position of conflict. For example, NPs cannot charge “dispensing fees” or obtain a profit from the sale of a medication.

NPs cannot obtain any benefit as a result of prescribing, dispensing or selling medication. A “benefit” is defined as any financial or non-financial incentive, whether direct or indirect, that conflicts with an NP’s professional or ethical duty to a client. NPs are expected to base treatment decisions on best available evidence, clinical judgment and client needs. NPs do not prescribe a particular medication because it is available for sale in the practice setting.

The practice expectations for public protection are described in the Nurse Practitioner practice standard.

Can NPs sell medication? Can I ask an administrative assistant to conduct the financial transaction associated with selling medication?

    • the client does not have reasonable access to a pharmacy
    • the client would not otherwise receive the medication
    • the client does not have the financial resources to otherwise obtain the medication, or
    • the medication is sold as part of a health promotion initiative.

Yes, NPs can sell medication. Before you sell a medication, you are accountable for assessing the client to determine that at least one of the following circumstances exists:

NPs cannot charge more than the actual cost of the medication, neither for personal financial gain nor to account for overhead or any other expense incurred.

Although NPs cannot delegate the sale of medication, if the above circumstances are met, an administrative assistant may conduct the financial transaction, which is the only one aspect involved in a sale.

For further information about the practice expectations for public protection when selling medication, see the Nurse Practitioner practice standard.

Page mise à jour le décembre 14, 2016